Published in Mol Biol (Mosk) on December 23, 1991
DNA hydrolyzing autoantibodies. Science (1992) 1.88
Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. Proc Natl Acad Sci U S A (1995) 1.08
Enzyme mimicry by the antiidiotypic antibody approach. Proc Natl Acad Sci U S A (2000) 0.99
Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol (1998) 0.96
DNA hydrolysis by monoclonal anti-ssDNA autoantibody BV 04-01: origins of catalytic activity. Mol Immunol (1997) 0.90
Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity. Appl Biochem Biotechnol (2000) 0.88
Blood Clotting Factor VIII: From Evolution to Therapy. Acta Naturae (2013) 0.86
Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol Lett (2002) 0.85
Immunoproteasome enhances intracellular proteolysis of myelin basic protein. Dokl Biochem Biophys (2014) 0.84
DNA-specific antiidiotypic antibodies in the sera of patients with autoimmune diseases. FEBS Lett (1992) 0.83
Suppression of ongoing experimental allergic encephalomyelitis in DA rats by novel peptide drug, structural part of human myelin basic protein 46-62. Autoimmunity (2009) 0.81
[A study of kinetics of endonuclease reactions using flow linear dichroism technique]. Mol Biol (Mosk) (1997) 0.81
Substrate specificity of catalytic autoantibodies in neurodegenerative processes. Dokl Biochem Biophys (2007) 0.80
DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies. Appl Biochem Biotechnol (1994) 0.80
[DNA-hydrolyzing antibodies in lymphoproliferative disorders]. Biull Eksp Biol Med (1996) 0.80
DNA hydrolysis by monoclonal autoantibody BV 04-01. Appl Biochem Biotechnol (2000) 0.79
Coagulation Factor IX for Hemophilia B Therapy. Acta Naturae (2012) 0.79
[A novel approach to the study of topoisomerase I kinetics]. Dokl Akad Nauk (1998) 0.78
Role of Structure-Based Changes due to Somatic Mutation in Highly Homologous DNA-Binding and DNA-Hydrolyzing Autoantibodies Exemplified by A23P Substitution in the VH Domain. Autoimmune Dis (2012) 0.78
DNA-hydrolyzing autoantibodies. Appl Biochem Biotechnol (1994) 0.78
Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system. Acta Naturae (2013) 0.78
Creation of catalytic antibodies metabolizing organophosphate compounds. Biochemistry (Mosc) (2012) 0.78
[Expression of human serum albumin in metylotrophic yeast Pichia pastoris and its structural and functional analysis]. Bioorg Khim (2008) 0.77
Stable Expression of Recombinant Factor VIII in CHO Cells Using Methotrexate-Driven Transgene Amplification. Acta Naturae (2012) 0.77
[Topoisomerase I from human placenta. Functional activity of products of expression of cloned cDNA fragments]. Mol Biol (Mosk) (1990) 0.77
[Antiviral etiotropic chemicals: efficacy against influenza A viruses A subtype H5N1]. Vopr Virusol (2006) 0.77
Antibodies-antidotes against organophosphorus compounds. Dokl Biochem Biophys (2009) 0.77
DNA-hydrolyzing Ab: is catalytic activity a clue for physiological significance? Autoimmunity (2009) 0.77
[Sensitivity of influenza A/H5 viruses isolated from wild birds on the territory of Russia to arbidol in the cultured MDCK cells]. Vopr Virusol (2006) 0.77
[Dna-specific catalytic antibodies in human blood sera]. Dokl Akad Nauk SSSR (1991) 0.77
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats]. Bioorg Khim (2012) 0.76
[Clinical trials of the new skin test Diaskintest for the diagnosis of tuberculosis]. Probl Tuberk Bolezn Legk (2009) 0.76
[Structural-functional study of recombinant forms of onconase]. Bioorg Khim (2001) 0.76
Substrate specificity of the anthrax lethal factor. Dokl Biochem Biophys (2008) 0.76
Site-specific degradation of myelin basic protein by the proteasome. Dokl Biochem Biophys (2009) 0.76
[Isolation and characteristics of catalytic antibodies to DNA in systemic lupus erythematosis]. Biokhimiia (1993) 0.76
[DNA-abzymes in rheumatoid arthritis: pathogenetic and clinical significance]. Ter Arkh (2005) 0.76
[Effectiveness of new diagnostic drug Diaskintest in children for tuberculosis diagnostic]. Probl Tuberk Bolezn Legk (2009) 0.76
[Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis]. Vestn Ross Akad Med Nauk (2010) 0.76
Natural antibody catalytic activities in mice with autoimmune disorders. Dokl Biochem (2001) 0.76
[Efficacy of arbidol in prophylaxis and treatment of acute respiratory viral infections in servicemen]. Voen Med Zh (2002) 0.75
Analysis of myelin basic protein fragmentation by proteasome. Acta Naturae (2009) 0.75
A novel preparative method for the isolation of avidin and riboflavin-binding glycoprotein from chicken egg-white by the use of high-performance liquid chromatography. Biochem J (1990) 0.75
[Functional degradation of myelin basic protein. Proteomic approach]. Bioorg Khim (2011) 0.75
[Antibodies to type I and II collagen in rheumatoid arthritis and chronic cicatricial stenosis of the larynx and trachea in children]. Sov Med (1989) 0.75
Cystathionase: high-performance liquid chromatography. Molecular cloning in lambda gt11. Nonradioactive immunodetection of fusion protein. Biochimie (1989) 0.75
[DNA-abzymes and their clinical significance in systemic lupus erythematosis]. Ter Arkh (2001) 0.75
Mediators and Biomarkers of Inflammation in Meningitis: Cytokine and Peptidome Profiling of Cerebrospinal Fluid. Biochemistry (Mosc) (2016) 0.75
[Catalytic autoantibodies as a new molecular instrument in rheumatological practice]. Ter Arkh (2006) 0.75
[Interaction of catalytically active antibodies with oligoribonucleotides]. Mol Biol (Mosk) (1995) 0.75
On the catalytic activity of autoantibodies in multiple sclerosis. Dokl Biochem Biophys (2004) 0.75
[Laccase from Coriolus hirsutus--a new marker enzyme for immunoenzyme analysis]. Prikl Biokhim Mikrobiol (1993) 0.75
[Serum factors regulating macrophage migration in chronic cicatricial stenosis of larynx and trachea in children]. Vestn Otorinolaringol (1991) 0.75
[Interaction of catalytically active antibodies with DNA]. Dokl Akad Nauk SSSR (1991) 0.75
[Gamma-cystathionase: the non-ideal gel filtration high performance liquid chromatography. Physico-chemical and immunochemical characteristics of the enzyme]. Mol Biol (Mosk) (1988) 0.75
Mechanism-dependent selection of immunoglobulin gene library for obtaining covalent biocatalysts. Dokl Biochem Biophys (2007) 0.75
Two subforms of eukaryotic topoisomerase I. Purification and structure-function relationships. FEBS Lett (1992) 0.75
Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects. Bull Exp Biol Med (2005) 0.75
[Anti-idiotypic antibodies to topoisomerase I in serum from patients with autoimmune diseases]. Dokl Akad Nauk SSSR (1991) 0.75
[Expression of the catalytic antibodies in eukaryotic systems]. Mol Biol (Mosk) (2011) 0.75
The antiidiotypic approach to obtaining a proteolytic antibody. Dokl Biochem Biophys (2008) 0.75
[Interactions of sera from patients with autoimmune diseases with cDNA expressed fragment of topoisomerase I and monoclonal antibodies against enzyme]. Biull Eksp Biol Med (1990) 0.75
[Efficacy of amixine in experimental hantavirus infection]. Vopr Virusol (2003) 0.75
[Furosemide in the terminal stage of chronic renal insufficiency]. Ter Arkh (1980) 0.75
[Antibody-mediated proteolysis of myelin-associated proteins as a new mechanism of control over demyelinization processes in multiple sclerosis]. Vestn Ross Akad Med Nauk (2007) 0.75
[Histomorphology and histochemistry of acquired scars of the laryngo-tracheal regions in children]. Vestn Otorinolaringol (1992) 0.75
[Catalytic autoantibodies and their future in practical medicine]. Ter Arkh (2002) 0.75
[Hemosorption in the complex treatment of patients with acute and chronic kidney failure]. Sov Med (1983) 0.75
[Introduction to medical abzymology: the present and the prospect]. Vestn Ross Akad Med Nauk (2005) 0.75
Avidin-peroxidase: synthesis and HPLC isolation of highly sensitive oligomers. J Biochem Biophys Methods (1991) 0.75
Study of the dynamics of supercoiled DNA. Dokl Biochem Biophys (2003) 0.75
[Etiology and pathogenesis of cicatricial stenosis of the larynx and trachea in children]. Vestn Otorinolaringol (1989) 0.75
[A structure-activity study of a catalytic antiidiotypic antibody to the human erythrocyte acetylcholinesterase]. Bioorg Khim (2002) 0.75
DNA-hydrolyzing autoantibodies in autoimmune pathologies. Ann N Y Acad Sci (1995) 0.75
[Improving surgical treatment of children with acquired cicatricial stenosis of the larynx and cervical part of the trachea]. Vestn Otorinolaringol (1992) 0.75
[Current pathogenetic model of rheumatoid arthritis and its role in clinical practice]. Ter Arkh (2004) 0.75
[Cystathionase: catalytic activity of products of expression of cDNA fragments. Specific inhibition of native enzyme and fusion-protein by substrate-like O-substituted hydroxylamine]. Dokl Akad Nauk (1996) 0.75
Pre-steady-state kinetics of interaction of wild-type and multiple drug-resistant HIV protease with first and second generation inhibitory drugs. Dokl Biochem Biophys (2011) 0.75
[Catalytic autoantibodies in autoimmune myocarditis: clinical and pathogenetic implications]. Ter Arkh (2005) 0.75
[From the editors of the special issue]. Bioorg Khim (2011) 0.75
[Pyridoxal phosphate-dependent enzymes of sulfur amino acid metabolism]. Biokhimiia (1989) 0.75
[Lasix pharmacokinetics and pharmacodynamics in acute renal insufficiency in the oliguria and anuria stage]. Urol Nefrol (Mosk) (1979) 0.75
[Expression Of DNA-Encoded Antidote to Organophosphorus Toxins in the Methylotrophic Yeast Pichia Pastoris]. Prikl Biokhim Mikrobiol (2016) 0.75
[Pharmacokinetics of ampicillin in patients with chronic renal insufficiency during hemodialysis and hemosorption]. Antibiot Med Biotekhnol (1985) 0.75